SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

This a repost of mine from yahoo site

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
vorlon1966 Member Profile
 
Followed By 30
Posts 654
Boards Moderated 0
Alias Born 12/05/13
160x600 placeholder
Advertisement
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/28/2015 4:03:35 PM
Provectus Biopharmaceuticals’ Abstract on Liver Cancer Accepted for Poster Presentation at 6th Asia-Pacific Primary Liver C... "Business Wire" - 5/28/2015 4:01:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/27/2015 4:07:40 PM
Provectus Biopharmaceuticals’s Abstract Accepted for Poster Presentation at 5th European Post-Chicago Melanoma / Skin Cance... "Business Wire" - 5/27/2015 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/18/2015 6:13:32 AM
Provectus Biopharmaceuticals Extends for Additional 60 Days Memorandum of Understanding with Sinopharm-China State Institute ... "Business Wire" - 5/18/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/14/2015 4:08:38 PM
Provectus Biopharmaceuticals’ Poster Presentation on PV-10 Clinical Data from Phase 1 Study for Cancers of the Liver Schedu... "Business Wire" - 5/14/2015 4:04:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/8/2015 8:02:55 AM
Provectus Biopharmaceuticals Updates Market on Business Developments "Business Wire" - 5/8/2015 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/7/2015 6:20:58 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/7/2015 6:12:28 AM
Provectus Biopharmaceuticals Reports First Quarter Financial Results "Business Wire" - 5/7/2015 6:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/5/2015 6:07:06 AM
Provectus Biopharmaceuticals’s Novel Synthesis Patent Application Allowed by European Patent Office, Patent Issued by Japan "Business Wire" - 5/5/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/30/2015 6:16:08 AM
Provectus Biopharmaceuticals’ Abstract on Liver Cancer Accepted for Poster Presentation at European Society for Medical Onc... "Business Wire" - 4/30/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/29/2015 6:10:08 AM
Provectus Biopharmaceuticals Will Hold Its Quarterly Business Update Conference Call at 4 PM Eastern, Thursday, May 7, 2015 "Business Wire" - 4/29/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/27/2015 6:10:59 AM
Provectus Biopharmaceuticals to Present at Asia Biotech Invest 2015 Conference Wednesday, May 20, 2015, Hong Kong "Business Wire" - 4/27/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/20/2015 6:04:59 AM
Provectus Biopharmaceuticals Opens Patient Enrollment; Begins Phase 3 International FDA Comparative Clinical Trial of PV-10 f... "Business Wire" - 4/15/2015 4:11:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/15/2015 4:04:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/8/2015 6:04:41 AM
vorlon1966   Saturday, 12/28/13 12:08:00 PM
Re: buccaneer1961 post# 919
Post # of 7780 
This a repost of mine from yahoo site answering questions and comments.

They never failed
They shut down photogen to start pvct when they figured out they had a better product
They did get paid a few years a bunch.... They also are getting a product to market for around $130mm instead of $1.5 billion and in less time than normal.... We benefited from that because there are no partners to share in the end game... Probably would not be an end game otherwise....they would have taken over and you might have gotten a few bucks increase instead of the big payoff that's coming
They did not go for pIII right away when they realized they could invent a new synthesis for rb that can be approved internationally for oncology....99% purity
Patent awarded this year ....you have to go into pIII with the drug that gets approved...so they waited for the patent
PIII? No mention in 8k..... What was mentioned was btd and aa
Deliberate omission? Judge for yourself.
Large production runs done for Nda and ready to ship...hmmmmm.
Second Pfizer guy on advisory board with Chinese pharma experience
They have been working on a Chinese regional deal waiting on FDA clarity....hmmmmm
First Pfizer board member is an acquisition specialist.....hmmmmm
They changed their name and state of incorporation......around same time as FDA meeting.....hmmmmm
Pfizer losing patents on Lipitor and Viagra .....hmmmmm

You guys not getting this......???? hmmmmmm...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist